Takeda Pharmaceutical to Establish New Sales and Marketing Company in London.Tokyo, Japan, June 29, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Takeda Pharmaceutical will establish a new sales and marketing company in London in July. To be capitalized Capitalized Recorded in asset accounts and then depreciated or amortized, as is appropriate for expenditures for items with useful lives longer than one year. at 4 million pounds, the new company will supervise Takeda's sales and marketing subsidiaries - Laboratories Takeda, Takeda UK Limited, Takeda Italia Farmaceutical S.p.A., Takeda Pharma GmbH, Takeda Pharma Ges.m.b.H, Takeda Pharma AG - in six European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. countries. Through the new sales arm, Takeda Pharmaceutical aims to reinforce its sales and marketing system and formulate formulate /for·mu·late/ (for´mu-lat) 1. to state in the form of a formula. 2. to prepare in accordance with a prescribed or specified method. and promote marketing strategies from its mid- and long-term plans. The new company will start operations in October. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion